Acaone 100mg - Acalabrutinib Capsules

Name: Acaone 100mg - Acalabrutinib Capsules
Brand: NEXT GEN BIOTECH
Price: 8500.0 INR
Availability: InStock

Price 8500.0 INR/ Bottle

Get a Price/Quote

MOQ : 1 Bottle

Acaone 100mg - Acalabrutinib Capsules Specification

Salt Composition
Acalabrutinib Capsules

Origin
India

Dosage Form
Capsules

Indication
Blood Cancer Treatment / Mantle Cell Lymphoma / Chronic Lymphocytic Leukemia

Enzyme Types
Other

Feature
Other

Ingredients
Other

Application
Other

Ph Level
N/A

Temperature Needed For Fermentation
30 Celsius (oC)

Physical Color/Texture
Other

Fermentation Smell
Normal Smell

Storage Instructions
Store in a cool and dry place away from direct sunlight and moisture.

Shelf Life
24 Months

Acaone 100mg - Acalabrutinib Capsules Trade Information

Minimum Order Quantity
1 Bottle

FOB Port
Delhi

Payment Terms
Cash Advance (CA), Cash in Advance (CID)

Supply Ability
500 Bottles Per Month

Delivery Time
5 Days

Sample Available
No

Sample Policy
Contact us for information regarding our sample policy

Packaging Details
Box

Main Export Market(s)
Asia

Main Domestic Market
All India

Certifications
N/A

About Acaone 100mg - Acalabrutinib Capsules

Acaone 100mg Capsule is an anticancer medicine containing the active constituent Acalabrutinib. It belongs to a class of drugs called Bruton's tyrosine kinase (BTK) inhibitors. It is used to treat mantle cell lymphoma (MCL), chronic lymphocytic leukaemia (CLL), and small lymphocytic lymphoma (SLL). MCL, CLL, and SLL are cancers of the white blood cells called lymphocytes that are part of the immune system. They differ from each other by the location where cancer occurs and the type of lymphocytes affected.

Before taking this medicine, inform your doctor if you have had recent surgery, bleeding problems, heart rhythm problems, infection, pregnancy, or breastfeeding. It is not recommended for children and adolescents less than 18 years old. This medicine can increase the risk of bleeding. Patients taking Acaone 100mg Capsule should be monitored for signs of bleeding and should avoid taking other medications that can increase the risk of bleeding, such as blood thinners.